Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCLCancersSeptember 16, 202210.3390/cancers14184491Cited by 10SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis